Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| HORIZON PHARMA, INC. | 3,688,294 | reported | 02 Mar 2012 | tx 15+3,568,880−1,757,559 |
| EXELIXIS, INC. | 574,776 | reported | 11 Aug 2004 | tx 25+10,000−927,400 |
| Oruka Therapeutics, Inc. | 313,483 | reported | 22 Oct 2012 | tx 7+573,413−140,000 |
| Korro Bio, Inc. | 194,655 | reported | 28 May 2026 | tx 8+1,164,349−2,860 |
| ImageneBio, Inc. | 17,520 | reported | 07 Jun 2024 | tx 16+10,300,127−34,010,376 |
| ACHILLION PHARMACEUTICALS INC | 15,000 | reported | 14 Dec 2007 | tx 5+1,983,670−14,843,044 |
| SGX PHARMACEUTICALS, INC. | 10,000 | reported | 17 May 2007 | tx 7+2,517,568−4,136,804 |
| Intellia Therapeutics, Inc. | 7,688 | reported | 14 Jun 2022 | tx 63+4,547,678−8,686,755 |
| Spero Therapeutics, Inc. | 7,500 | reported | 17 Aug 2021 | tx 16+2,397,901−10,507,362 |
| Egalet Corp | 0 | reported | 11 Feb 2014 | tx 11+2,152,222−1,726,852 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | SALE | Korro Bio, Inc. | 2,441 | 13.95 USD | 10b5-1 |
| 28 May 2026 | SALE | Korro Bio, Inc. | 419 | 13.95 USD | 10b5-1 |
| 11 Jun 2025 | GRANT_AWARD | Korro Bio, Inc. | 6,010 | 0.00 USD | deriv |
| 11 Jun 2024 | GRANT_AWARD | Korro Bio, Inc. | 5,190 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | ImageneBio, Inc. | 17,520 | 0.00 USD | deriv |
| 22 Apr 2024 | GRANT_AWARD | Korro Bio, Inc. | 17,857 | 56.00 USD | |
| 03 Nov 2023 | GRANT_AWARD | Korro Bio, Inc. | 177,217 | — | |
| 03 Nov 2023 | GRANT_AWARD | Korro Bio, Inc. | 942,075 | — | |
| 03 Nov 2023 | GRANT_AWARD | Korro Bio, Inc. | 16,000 | 0.00 USD | deriv |
| 09 Jun 2023 | GRANT_AWARD | ImageneBio, Inc. | 17,520 | 0.00 USD | deriv |
| 14 Jun 2022 | GRANT_AWARD | Intellia Therapeutics, Inc. | 5,197 | 0.00 USD | |
| 14 Jun 2022 | GRANT_AWARD | Intellia Therapeutics, Inc. | 7,688 | 0.00 USD | deriv |
| 09 Jun 2022 | GRANT_AWARD | ImageneBio, Inc. | 13,419 | 0.00 USD | deriv |
| 21 Dec 2021 | GRANT_AWARD | ImageneBio, Inc. | 13,419 | 0.00 USD | deriv |
| 30 Mar 2021 | PURCHASE | ImageneBio, Inc. | 125,000 | 16.00 USD | first after silence |
| 14 Dec 2021 | SALE | ImageneBio, Inc. | 5,959 | 14.00 USD | |
| 13 Dec 2021 | SALE | ImageneBio, Inc. | 8,330 | 14.64 USD | |
| 10 Dec 2021 | SALE | ImageneBio, Inc. | 11,989 | 15.03 USD | |
| 14 Sept 2021 | SALE | Translate Bio, Inc. | 2,055,063 | 38.00 USD | |
| 14 Sept 2021 | SALE | Translate Bio, Inc. | 37,800 | 0.00 USD | deriv |
| 14 Sept 2021 | SALE | Translate Bio, Inc. | 18,900 | 0.00 USD | deriv |
| 14 Sept 2021 | SALE | Translate Bio, Inc. | 20,000 | 0.00 USD | deriv |
| 14 Sept 2021 | SALE | Translate Bio, Inc. | 18,900 | 0.00 USD | deriv |
| 17 Aug 2021 | GRANT_AWARD | Spero Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 28 Jun 2021 | SALE | Intellia Therapeutics, Inc. | 21,893 | 135.83 USD |
4 purchases reported after at least 12 months of silence — most recent on 30 Mar 2021.